Form 4: Exelixis CSO Dana Aftab Reports Stock Transactions Following Vesting of Performance-Based Restricted Stock Units

Exelixis CSO Dana Aftab reports the withholding of 12,838 shares for tax obligations and the holding of 486,107 shares directly and 5,835 shares indirectly through a 401(k) plan.

Summary

• Dana Aftab, the Chief Scientific Officer and Executive Vice President of Discovery and Translational Research at Exelixis, Inc., filed a Form 4 detailing changes in beneficial ownership of company stock.
• The filing indicates that 12,838 shares of common stock were withheld to cover tax obligations related to the vesting of performance-based restricted stock units.
• These restricted stock units were initially awarded on September 11, 2020, and the performance criteria were certified as achieved on September 6, 2023.
• Following these transactions, Aftab directly owns 486,107 shares of Exelixis common stock, which includes 263,602 shares that will be issued upon the vesting of restricted stock units.
• Additionally, Aftab indirectly owns 5,835 shares of common stock through the Exelixis, Inc. 401(k) Plan.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing detailing stock transactions by an executive, which is neither positive nor negative in itself. It reflects standard compensation practices.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common in the biotechnology industry. It reflects the vesting of equity-based compensation and is a normal part of executive compensation practices.

Comparison to Industry Standards

• Stock transactions by executives are a standard practice across publicly traded companies, particularly in the biotech sector where equity compensation is common.
• The vesting of restricted stock units and the subsequent tax withholding are typical components of executive compensation packages.
• Companies like Gilead Sciences, Amgen, and Biogen also regularly report similar transactions by their executives through SEC filings.

Stakeholder Impact

• The stock transactions have a minor impact on shareholders as they reflect the vesting of previously awarded compensation.
• The transactions do not have a significant impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Exelixis, Form 4, Beneficial Ownership, Stock Transactions, Restricted Stock Units, Dana Aftab, Tax Withholding, 401(k)